3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
STARRY SEA ACQUISITION CORP disclosed that the redemption deadline for its Extraordinary General Meeting expired on October 15, 2026, with 3,895,270 public shares still tendered for redemption after 601,847 requests were withdrawn. The meeting, postponed to 9:00 a.m. Eastern Time on October 19, 2026, is the point at which these redemptions would be processed, so the figure bears directly on how many public shares remain outstanding.
Redemption deadline expired at 5:00 p.m. Eastern Time on October 15, 2026.
601,847 redemption requests were withdrawn as of the deadline.
3,895,270 public shares remain tendered for redemption, including requests received between October 7 and October 15, 2026.
The meeting was postponed from October 9 to 9:00 a.m. Eastern Time on October 19, 2026, to allow more time to engage with shareholders.
On October 16, 2026, the company filed prospectus supplements and entered agency agreements to continue or establish programs for Member Capital Securities, Medium-Term Notes, InterNotes and Retail Subordinated Notes. The filing sets up the framework for future sales of these securities but states no amounts sold, prices or proceeds, and it reports no financial results.
Four programs covered: Member Capital Securities, Series 2026; Medium-Term Notes, Series D; CFC InterNotes; and Retail Subordinated Notes.
Each program is described as an unlimited aggregate principal amount that may be offered from time to time.
Securities will be issued under a Form S-3 shelf registration filed October 14, 2026 (File No. 333-299452).
Conduent and two subsidiaries entered a class action settlement agreement on October 16, 2026, to resolve a consolidated lawsuit over the company's January 2025 cybersecurity incident. The settlement requires a non-reversionary $80 million fund and takes effect only if the U.S. District Court for the District of New Jersey approves it. The company says it maintains cyber insurance and does not expect a material impact on its financial position, results of operations or cash flows.
Company will fund $80 million into a non-reversionary settlement fund, its total monetary obligation under the agreement
Fund covers class member recovery, credit and medical data monitoring, plaintiffs' counsel fees and administration costs
Settlement releases the company, affected clients and their customers from claims tied to the cyber incident upon final approval
Agreement is not an admission of fault and remains subject to Court approval
On October 16, 2026, Cipher Digital issued $850.0 million of 0.00% convertible senior notes maturing November 1, 2032, with a 13-day option for initial purchasers to buy up to $150 million more. The company also entered capped call transactions costing about $89.7 million, which are expected to reduce potential dilution from conversions, and agreed to exchange about $165.9 million of its 2030 notes for about 40.7 million shares of common stock. The notes add debt and could dilute shareholders if converted, though the filing says the capped calls are expected to offset some of that dilution.
$850.0 million principal of 0.00% convertible senior notes due November 1, 2032; initial purchasers have a 13-day option for up to an additional $150,000,000
Initial conversion price of about $15.31 per share (65.3211 shares per $1,000 principal)
Capped call transactions cost about $89.7 million, with a cap price of $28.35, a 150% premium over the October 13, 2026 last sale price
Concurrent exchange of about $165.9 million of 1.75% 2030 notes for about 40.7 million shares of common stock
LifeStance Health Group disclosed that director Teresa DeLuca, M.D., notified the board on October 14, 2026, of her resignation from the board and all of its committees, effective December 31, 2026. The company states the resignation is not the result of any disagreement with the company.
Teresa DeLuca, M.D., resigns from the board of directors and all committees.
Resignation notified to the board on October 14, 2026, effective December 31, 2026.
Company states the resignation does not result from any disagreement with Dr. DeLuca.
Filing does not name a replacement director or describe any financial effect.
Enova International and Grasshopper Bancorp mutually terminated their December 2025 merger agreement on October 16, 2026. Enova made a $4,000,000 cash payment to Grasshopper, and neither party owes other fees or liabilities related to the agreement.
Merger agreement dated December 10, 2025, amended December 18, 2025, is now terminated effective October 16, 2026
Enova paid Grasshopper a $4,000,000 cash payment under the Mutual Termination Agreement and Release
No other fees or liabilities are owed by either party related to the merger agreement
Termination agreement is filed as Exhibit 10.1; General Counsel Sean Rahilly signed the report
Titan International entered a deferred compensation arrangement with CEO Paul G. Reitz worth $2.3 million, with payments not starting until 2030. The company funds the obligation by placing about 332,370 shares of common stock in an irrevocable rabbi trust, where assets remain subject to general creditors in insolvency.
Deferred compensation of $2.3 million awarded to CEO Paul G. Reitz under a plan approved by the Board on October 12, 2026
Payments will not begin until 2030, paid as a lump sum or installments as Mr. Reitz elects
About 332,370 shares, valued at approximately $2.3 million, will be contributed to the rabbi trust, which the Trustee votes
Trust assets remain subject to general creditors if the company becomes insolvent
SentinelOne completed a private offering of $1.25 billion of 0.00% convertible senior notes due October 1, 2031, with the $187.5 million over-allotment option exercised in full. The notes are unsecured and bear no regular interest, but they add debt, and conversion could dilute existing shareholders if the stock rises above the initial conversion price of about $31.21.
$1.25 billion of 0.00% convertible senior notes due October 1, 2031, including full exercise of the $187.5 million option
Initial conversion price of about $31.21 per share, a 30.0% premium over the $24.01 close on October 13, 2026
About $150.0 million of proceeds used to repurchase about 6.2 million Class A shares from note purchasers at $24.01 per share
Capped call transactions cost about $131.6 million, with a cap price of $48.02 per share, intended to reduce potential dilution
NRx Pharmaceuticals set December 17, 2026 as the date for its 2026 annual meeting of stockholders, which will be virtual-only, and October 28, 2026 as the record date for voting. The filing also sets revised deadlines for stockholder proposals and director nominations, which shareholders who want to act at the meeting need to meet.
2026 Annual Meeting: December 17, 2026, 10:00 a.m. Eastern Time, virtual-only by live webcast
Record date for stockholders entitled to vote: October 28, 2026
Rule 14a-8 proposal and advance notice deadline: close of business October 25, 2026
Universal proxy notice deadline under Rule 14a-19: October 26, 2026
The filing, which names Adial Pharmaceuticals, Inc. as the filer, says the company adjourned its 2026 Annual Meeting of Stockholders for a second time on October 15, 2026, for votes on Proposals 3, 4, 5 and 6. The company had not yet received Nasdaq's approval of its Initial Listing Application, which it submitted in connection with those proposals. Shareholders who already voted on those proposals need not act unless they want to change their vote.
Proposals 3, 4, 5 and 6 remain open; the meeting will reconvene on October 26, 2026, at 8:30 a.m. Eastern Time.
Proposals 1, 2, 7, 8, 9, 10, 11 and 12 were voted on at the September 17, 2026 session.
Nasdaq approval of the Initial Listing Application was still pending as of October 15, 2026.
The record date remains August 17, 2026, and no changes were made to the proposals.
On October 14, 2026, Silver Bow Mining's board approved a grant of 2,000,000 performance warrants to CEO C. Travis Naugle, subject to NYSE American and any required shareholder approval. The board also amended 200,000 existing performance warrants, replacing a preliminary economic assessment milestone with milestones tied to the pending Jefferson County Metallurgical Complex acquisition and a term sheet with Ocean Partners UK Limited.
New warrants allow purchase of up to 2,000,000 common shares, with exercise prices of $12.00 for four milestones and $18.00 for the production milestone
The grant date will be the date shareholders approve the new warrants under NYSE American rules; no shares may be issued before then
Montana Tunnels milestones, including the September 8, 2026 initial closing of the Jefferson County acquisition and the September 21, 2026 term sheet, were deemed achieved as of October 2, 2026
The term sheet provides for a potential funding and credit support package of approximately $88 million
Iambic Therapeutics filed an amended and restated certificate of incorporation and adopted amended and restated bylaws on October 16, 2026, in connection with completing its initial public offering. The filing refers to the prospectus filed October 15, 2026 for the full description of the new governing documents, which set out the company's shareholder framework now in effect.
Restated Certificate of Incorporation filed with Delaware Secretary of State on October 16, 2026, tied to the IPO completion
Restated Bylaws adopted effective October 16, 2026, described in the October 15, 2026 final prospectus
Item 7.01 notes the company may use its website, social media and other channels to disclose material information
NioCorp's majority-owned subsidiary Elk Creek Resources signed an Offtake Agreement with Traxys North America on October 13, 2026, replacing prior ferroniobium and scandium offtake agreements with Traxys. The deal gives Traxys take-or-pay purchase rights on 50% of annual ferroniobium output and exclusive marketing rights for 100% of other Elk Creek products, which matters to shareholders because it sets the sales framework for the project's planned output.
Agreement dated October 13, 2026, between Elk Creek Resources and Traxys North America LLC
Traxys to buy 50% of annual ferroniobium production on a take-or-pay basis, or 3,700 metric tonnes per year at Traxys' election
Term of 15 years from the Commercial Production Date, followed by two automatic one-year renewals
Either party may terminate if the Export-Import Bank of the United States has not given final approval of senior debt financing by December 31, 2027
PharmaCyte Biotech's Audit Committee dismissed CBIZ CPAs as its independent registered public accounting firm on October 14, 2026, and engaged Grassi & Co., CPAs as its replacement. The filing reports no adverse or qualified audit opinions from CBIZ CPAs for fiscal 2026 and 2025, but it discloses material weaknesses in internal control tied to segregation of duties of the Chief Financial Officer and management review controls.
Dismissal of CBIZ CPAs effective October 14, 2026; CBIZ CPAs' reports for fiscal years ended April 30, 2026 and 2025 contained no adverse opinion, disclaimer, or qualification
Grassi & Co. approved October 14, 2026 to audit fiscal year ending April 30, 2027 and review interim statements starting with the quarter ending October 31, 2026
Disclosed material weaknesses relate to insufficient segregation of duties of the Chief Financial Officer and insufficient management review controls
CBIZ CPAs letter dated October 16, 2026 filed as Exhibit 16.1
TuHURA Biosciences borrowed an additional $650,000 on October 9, 2026, under a revolving credit facility with Parkview Holdings One LLC, as disclosed in a Form 8-K filed October 16, 2026. The company said it expects to use the funds for general corporate purposes, and the draw is small relative to the $50 million maximum availability under the facility.
Draw of $650,000 received and borrowed on October 9, 2026
Revolving credit facility under Loan Agreement dated April 21, 2026, with a maximum loan availability of $50 million
Facility matures April 21, 2031; the company expects to use funds for general corporate purposes
Filing notes risks including potential conflicts of interest from the loan with an affiliate of the largest stockholder
On October 16, 2026, Mary Szela resigned from the board of Averin Capital Acquisition Corp. and from its audit and compensation committees, effective the same day, and the filing says the resignation was not due to any disagreement with the company. The board filled the open seats by naming Graeme Bell as compensation committee chairperson and Akiko Moni Miyashita as an audit committee member, both effective October 16, 2026.
Mary Szela resigned from the board, the audit committee and as chair of the compensation committee, effective October 16, 2026.
The filing states her resignation was not the result of any disagreement with the company on operations, policies or practices.
Graeme Bell was appointed compensation committee chairperson and Akiko Moni Miyashita was appointed to the audit committee, both effective October 16, 2026.
Waterstone Financial, Inc. said director Derek L. Tyus resigned from the boards of the company and WaterStone Bank SSB, effective October 20, 2026, citing a new professional commitment. The filing states the resignation did not result from any disagreement with the company or bank on operations, policies or practices.
Derek L. Tyus resigned from the Boards of Directors of the Company and the Bank, effective October 20, 2026.
Tyus joined the boards in 2021 and served on the Audit and Compensation Committees of the Company Board and the Bank Board's Executive Committee.
The company said the resignation was due to a new professional commitment and was not the result of any disagreement.
Chairman Patrick S. Lawton thanked Tyus for his service in the press release.
Live Nation closed private offerings of $730 million of 7.125% U.S. dollar senior notes and €600 million of 6.125% euro senior notes, both due 2032, and plans to use the proceeds to redeem its 6.500% senior secured notes due 2027. The company also amended its senior secured credit facilities, extending their maturity by one year to October 21, 2031 and increasing several commitments, which shareholders may watch as the company's debt structure changes.
Notes closed October 15, 2026: $730 million at 7.125% and €600 million at 6.125%, both maturing October 15, 2032.
Proceeds are intended to fund full redemption of the 6.500% senior secured notes due 2027, plus fees, expenses and general corporate purposes.
After cross-currency swaps, the weighted average interest rate on the notes is approximately 5.89% per annum, compared with 6.500% on the notes being redeemed.
Credit agreement amendment extends revolving and delayed draw term loan A maturities to October 21, 2031, with commitments of $1,450 million, $435 million and $725 million.
Costco's board committees approved fiscal 2027 bonus criteria for executive officers, tying payouts to sales, pre-tax income and environmental and social metrics. The filing sets base bonus amounts for the CEO and other executive officers, with payouts scaling by performance.
CEO base bonus of $1.2 million for fiscal 2027, split $500,000 on sales targets and $500,000 on pre-tax income targets, plus up to $200,000 on environmental and social metrics
Other executive officers have base bonuses of $400,000, split $160,000 on sales and $160,000 on pre-tax income, plus up to $80,000 on environmental and social objectives
Each financial goal can pay from zero up to 120% of target; criteria approved October 13, 2026
Eaton filed a Form 8-K on October 16, 2026 to recast segment information in its 2025 Form 10-K, combining the legacy Vehicle and eMobility segments into one Mobility segment after a first-quarter 2026 reorganization. The company says the changes are not a restatement of its financial statements, and the filing does not update results or events after the original 10-K. For shareholders, this changes how segment results are presented rather than reporting new performance.
Exhibit 99.1 recasts Items 1, 7, 8 and 15 of the 2025 Form 10-K, which was originally filed February 26, 2026
Vehicle and eMobility segments are combined into a new Mobility segment, effective with the reorganization in the first quarter of 2026
The filing states it does not amend or restate the audited 2025 financial statements; the auditor's report is dual-dated October 16, 2026
Kingstone Companies (KINS) said it will release third quarter 2026 financial results after the market closes on November 5, 2026, followed by a conference call on November 6, 2026 at 8:30 a.m. ET. The filing is a scheduling notice and contains no financial results, so it does not indicate how the quarter performed.
Third quarter 2026 results release after market close on Thursday, November 5, 2026
Conference call at 8:30 a.m. ET on Friday, November 6, 2026; U.S. toll-free dial-in 1-877-407-2991
Replay of the webcast to remain accessible for approximately 30 days after the call
Alector, Inc. agreed on October 15, 2026 to sell 36,600,000 new shares of common stock at $2.05 per share through underwriters Morgan Stanley and BTIG, with expected gross proceeds of $75,030,000 before underwriting discounts and offering expenses. The offering is expected to close on October 19, 2026, and the company plans to use the net proceeds for general corporate purposes, including research, development and manufacturing. Because the company is issuing new shares, existing shareholders will own a smaller percentage of the company after closing.
Pricing: 36,600,000 shares at $2.05 per share, a premium of about 7.3% over the October 15, 2026 closing price
Expected gross proceeds of $75,030,000 before underwriting discounts and offering expenses
Expected closing on or about October 19, 2026, subject to customary conditions
Underwriters are Morgan Stanley & Co. LLC and BTIG, LLC; the offering is made under an effective Form S-3 shelf registration
CalciMedica's Chief Financial Officer, principal accounting officer and principal financial officer, Stephen Bardin, gave notice of his resignation on October 15, 2026, to pursue another professional opportunity. The resignation takes effect immediately after the company files its Form 10-Q for the quarter ended September 30, 2026, and the company said it was not due to any disagreement.
Stephen Bardin is CFO, principal accounting officer and principal financial officer.
Notice given October 15, 2026; effective immediately after the Q3 2026 Form 10-Q is filed.
Resignation is to pursue another professional opportunity, and the company states no disagreement was involved.
The filing names no successor or interim financial officer.
TScan Therapeutics disclosed that directors Garry Nicholson and Gabriela Gruia, M.D., resigned from its Board of Directors and all board committees, effective October 13, 2026, with no disagreement with the company cited. The board filled the vacancies on its committees, appointing Stephen Biggar and R. Keith Woods to the Nominating and Corporate Governance Committee, which matters to shareholders as a change in board composition and committee makeup.
Garry Nicholson and Gabriela Gruia, M.D., resigned from the board and all committees effective October 13, 2026.
The filing states the resignations were not due to any disagreement with the company on operations, practices or policies.
Stephen Biggar (member) and R. Keith Woods (chairperson) were appointed to the Nominating and Corporate Governance Committee effective October 13, 2026.
The Audit Committee now consists of Katina Dorton, Barbara Klencke and R. Keith Woods.
Post Holdings said its Senior Vice President and Chief Accounting Officer, Bradly A. Harper, is taking a temporary medical leave, with CFO Matthew J. Mainer serving as interim principal accounting officer. The board also approved an updated Code of Conduct, effective February 1, 2027, that adds new content on areas such as artificial intelligence and cybersecurity while stating it does not waive any provision of the prior code.
Bradly A. Harper, SVP and Chief Accounting Officer, is on temporary medical leave; the filing gives no return date.
Matthew J. Mainer, EVP, CFO and Treasurer, is interim Chief Accounting Officer and principal accounting officer during the leave.
Board approved the New Code on October 15, 2026; it takes effect February 1, 2027 and supersedes the Prior Code.
New Code adds content on artificial intelligence, prediction markets and fraud prevention, and expands topics including cybersecurity and conflicts of interest.
Alliance Entertainment's Compensation Committee approved a raise in the annual base salary of Chief Financial Officer Amanda Gnecco to $350,000, effective October 1, 2026, up from $247,200. The filing also sets her prorated fiscal 2027 target bonus at $81,075, a routine compensation change with no stated effect on company results.
CFO Amanda Gnecco's annual base salary rises to $350,000 from $247,200, effective October 1, 2026.
Her prorated target annual bonus for the fiscal year ending June 30, 2027, is $81,075.
The Compensation Committee authorized the change on October 12, 2026; the 8-K was dated October 16, 2026.
PepsiCo issued two tranches of €500 million each: 3.750% senior notes due October 16, 2029, and 4.250% senior notes due October 16, 2035, with the notes issued October 16, 2026. The company received net proceeds of about €994 million, which it will use for general corporate purposes, including repaying commercial paper. The notes are unsecured and rank equally with PepsiCo's other unsecured senior debt, so this is a routine debt financing that the filing does not tie to any change in earnings or guidance.
Two €500 million tranches: 3.750% notes due October 16, 2029 and 4.250% notes due October 16, 2035
Prices to public were 99.953% for the 2029 notes and 99.824% for the 2035 notes
Net proceeds of about €994 million for general corporate purposes, including repaying commercial paper
Joint book-running managers were Deutsche Bank AG, London Branch and HSBC Bank plc
Bank of Marin and Brandi Campbell, its Executive Vice President and Head of Retail Banking, mutually agreed that her employment would end on October 16, 2026, under a separation agreement effective that day. In exchange for a release of claims, she is entitled to three months' pay in a lump sum and nine months of COBRA premium reimbursement. The filing does not name a successor, so shareholders will need to watch for an update on who will lead retail banking.
Employment termination date: October 16, 2026, mutually agreed by the Bank and Ms. Campbell
Severance: three months' pay in a lump sum, less applicable deductions and withholdings
Benefits: nine months of reimbursement for COBRA premiums, in exchange for a release of claims
Filing signed October 16, 2026 by CFO David Bonaccorso
The fund's board approved a name change to The NXG Cushing Energy Infrastructure Fund and a shift in its 80% investment policy from midstream energy to energy infrastructure, both effective December 18, 2026. The adviser says the fund's portfolio, at 90% energy infrastructure as of October 15, 2026, needs no rebalancing, the ticker stays SRV, and shareholders need not take action.
Name changes to The NXG Cushing Energy Infrastructure Fund effective December 18, 2026; NYSE ticker SRV and CUSIP 231631300 are unchanged.
The 80% policy now covers energy infrastructure investments instead of midstream energy investments, effective December 18, 2026.
As of October 15, 2026, 90% of net assets plus borrowings were in energy infrastructure investments, so no portfolio changes are expected.
No change to the investment adviser or portfolio management personnel; no shareholder action is required.
TOMI Environmental Solutions appointed Niroshan Srirathan, its interim chief financial officer, as permanent CFO, effective immediately, with the board action dated October 11, 2026. He has an annual base salary of $205,000 under an offer letter, and the company says the full letter will be filed as an exhibit to its next periodic report.
Board appointed Niroshan Srirathan, age 39, as permanent Chief Financial Officer on October 11, 2026, effective immediately.
Srirathan previously served as Interim CFO since May 16, 2026, and as Controller since May 4, 2026.
Annual base salary under the offer letter is $205,000.
The filing states no family relationships with directors or executive officers and no reportable related-person transactions.
Global Partners LP and certain subsidiaries entered into an amendment to their credit agreement on October 16, 2026, extending the facility's maturity from March 20, 2028 to October 16, 2031. The $1.0 billion working capital commitment and $500 million revolver commitment were maintained, while a $0 interim commitment replaced the previously extended working capital interim commitment.
Maturity extended from March 20, 2028 to October 16, 2031
Aggregate WC Commitment of $1.0 billion and Aggregate Revolver Commitment of $500 million maintained
Previously extended Aggregate WC Interim Commitment reduced to $0
Certain lenders may assign all or part of their loans and commitments to other lenders
Ocular Therapeutix said its Chief Strategy Officer, Sanjay Nayak, resigned, effective October 16, 2026, to become CEO of a privately held company. The filing does not name a successor or describe any transition arrangements.
Sanjay Nayak notified the company of his resignation on October 14, 2026.
Resignation is effective October 16, 2026.
He is leaving to become Chief Executive Officer of a privately held company, which the filing does not name.
The filing does not name a successor or give financial terms.
Asure Software entered a $115 million senior credit facility with MUFG Bank on October 15, 2026, drawing the full $85.0 million term loan at closing and using proceeds to repay about $62.6 million owed under its MidCap credit agreement. The company also bought payroll processing assets from a southeastern US seller for $26.5 million, paying partly in newly issued common stock, which adds new debt and dilutes existing holders slightly.
$85.0 million term loan drawn October 15, 2026; $10.0 million revolver and $20.0 million delayed-draw term loan remain undrawn
Interest at Term SOFR plus 3.00%, initial three-month rate of 7.04249%; principal payments begin April 1, 2027, with maturity October 15, 2031
Paid $62.6 million to MidCap to retire the prior credit agreement and note, including $2.4 million in prepayment and termination fees
Acquisition price of $26.5 million included $13.5 million cash, a $3.0 million note, and 1,206,141 shares valued at $10.0 million
Quantum Cyber N.V. appointed Major General (Retired) Alberto C. Rosende as an independent director effective October 12, 2026, filling a board vacancy, and named him to the Audit, Compensation, and Nomination committees. The same day, Peter M. O'Rourke resigned from the board and as President of subsidiary Quantum Drones Corporation, and his employment agreement was terminated; the filing says the resignation was not due to a disagreement with the company.
Alberto C. Rosende appointed director effective October 12, 2026, with a term until the 2027 annual general meeting
Rosende named to the Audit, Compensation, and Nomination committees; board determined he is independent under Nasdaq rules
Peter M. O'Rourke resigned from the board and as President of Quantum Drones Corporation effective October 12, 2026
O'Rourke's employment agreement, effective July 1, 2026, was terminated; filing states no disagreement with the company
Carlyle Secured Lending, Inc. (CGBD) said it will report its third quarter 2026 financial results on Thursday, November 5, 2026, and host a conference call on Friday, November 6, 2026 at 11:00 a.m. Eastern Time. The announcement is a scheduling notice and contains no financial results, so it does not change the company's reported performance for shareholders.
Quarterly results for the period ended September 30, 2026 to be reported on Thursday, November 5, 2026
Conference call set for Friday, November 6, 2026 at 11:00 a.m. Eastern Time, with webcast on carlylesecuredlending.com
Filing furnishes the October 16, 2026 press release as Exhibit 99.1 and is not deemed filed under Section 18
Kimbell Royalty Partners, LP delivered notice on October 16, 2026 to redeem 81,250 Series A Cumulative Convertible Preferred Units, half of those outstanding, on November 16, 2026. The redemption price is $1,233.37895 per unit, for an aggregate of approximately $100.2 million, and the partnership expects to fund it with borrowings under its revolving credit facility.
81,250 Preferred Units, half of those outstanding, called for redemption
Redemption price of $1,233.37895 per Preferred Unit, about $100.2 million in aggregate
Redemption date is November 16, 2026
Expected to be funded with borrowings under the partnership's revolving credit facility
Ainos's board approved Second Amended and Restated Bylaws on October 14, 2026, effective immediately, dividing directors into three classes with staggered three-year terms. The board also amended its Corporate Governance Policies to reflect the new structure, so shareholders will elect only one class of directors at each annual meeting.
Board unanimously approved the restated bylaws on October 14, 2026, effective immediately
Class I (term expires at 2026 annual meeting): Ting-Chuan Lee, Chun-Jung Tsai, Chung-Yi Tsai
Class II (term expires at 2027 annual meeting): Yao-Chung Chiang, Pao-Sheng Wei; Class III (term expires at 2028 annual meeting): Chun-Hsien Tsai, Wen-Han Chang
Amended Corporate Governance Policies filed as Exhibit 99.1; restated bylaws filed as Exhibit 3.1
Christopher J. Hagedorn, the company's Executive Vice President & Chief Strategy Officer, is leaving on September 30, 2026, under a Separation Agreement signed October 13, 2026. The agreement provides 24 months of salary, a bonus amount equal to 2.0 times his target bonus, and other benefits, and forfeits his unvested equity awards.
Departure date: September 30, 2026; separation agreement signed October 13, 2026
Severance includes 24 months of salary and a bonus amount equal to 2.0 times his target bonus, paid in two installments
Unvested stock options and performance units granted in 2024, 2025 and 2026 are forfeited; 57,033 options granted November 16, 2023 vested in full
Incentive payout for fiscal 2026 is scheduled for November 2026 and will depend on actual performance results
Bio Green Med Solution, Inc. (BGMS) said its Board of Directors declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock on October 15, 2026. The dividend is payable November 1, 2026, to preferred holders of record at the close of business on October 26, 2026. The filing covers a routine preferred dividend and does not report financial results or changes to common stock.
Quarterly cash dividend of $0.15 per share on the 6% Convertible Exchangeable Preferred Stock
Declared by the Board of Directors on October 15, 2026
Payable November 1, 2026; record date is October 26, 2026
FiEE, Inc. entered into indemnification agreements with its directors and executive officers, including Angel Colon, who joined the board, on October 12 and October 15, 2026. The agreements require the company to indemnify covered individuals against certain liabilities from their service and to advance certain expenses, and they replace existing indemnification agreements. The filing contains no financial results, and the terms are standard governance arrangements that do not change the company's financial position as stated.
Angel Colon entered into an indemnification agreement on October 12, 2026, in connection with his board appointment.
Cao Yu, Chan Oi Fat, Hu Bin, Hongya Wen and Li Wai Chung signed the same form of agreement on October 15, 2026.
The new agreements superseded and replaced each person's existing indemnification agreement.
SITE Centers Corp. notified the New York Stock Exchange on October 15, 2026 that it intends to voluntarily delist its common shares. The company plans to file a Form 25 on November 23, 2026, and expects the delisting to take effect before trading begins on December 4, 2026. The notice follows the sale of the company's interests in the Dividend Trust Portfolio joint venture.
Notice to NYSE provided October 15, 2026, under authority granted by the Board of Directors
Form 25 filing intended for November 23, 2026
Delisting expected to be effective before trading commences on December 4, 2026
Action follows the sale of the company's interests in the Dividend Trust Portfolio joint venture
On October 13, 2026, subsidiary Organovo, Inc. signed a Second Amendment to its lease for the company's principal executive offices at 11555 Sorrento Valley Road, San Diego, with San Diego Inspire 2, LLC. The amendment reduces the leased space, extends the term for Suite 100 through April 30, 2028, and sets a temporary rent abatement, and the filing does not state a financial impact on the company beyond these lease terms.
Company must vacate and surrender Suite 202 on or before February 28, 2027
Term for Suite 100 extended from March 1, 2027 through April 30, 2028
Monthly base rent adjusted to $43,072.85
Rental abatement of $21,536.43 per month from March 1, 2027 through June 30, 2027, totaling $86,145.70
Maze Therapeutics entered into an exchange agreement on October 15, 2026, with four Frazier Life Sciences funds. Maze exchanged 2,776,007 shares of common stock held by the funds for pre-funded warrants to buy the same number of shares, at an exercise price of $0.001 per share. The filing says the exchange does not change the total count of shares outstanding in the way a new issuance would, but it does create warrants that could later be converted into common stock.
Exchange agreement dated October 15, 2026, with Frazier Life Sciences Public Fund, L.P. and affiliated Frazier funds
2,776,007 shares of common stock exchanged for pre-funded warrants with an exercise price of $0.001 per share
Outstanding common stock was 53,931,889 shares as of October 16, 2026, after giving effect to the exchange
Warrants cannot be exercised if the holder would own more than 9.99% of outstanding common stock, subject to certain exceptions
AT&T said Lori M. Lee, its Global Marketing Officer and Senior Executive Vice President of International, will retire effective December 31, 2026. The company said her role will be eliminated as part of a divestiture of its Mexico wireless business and other reorganization efforts. The filing does not disclose financial results or the terms of the Mexico sale.
Lori M. Lee announced her retirement on October 14, 2026, effective December 31, 2026.
Her role is being eliminated in connection with the Mexico wireless business divestiture and other reorganization.
AT&T announced on October 13, 2026 that it agreed to sell its wireless business in Mexico.
Carlyle Credit Income Fund disclosed in a Form 8-K that management's unaudited net asset value per common share was $3.05 as of September 30, 2026. The filing gives only this figure and no prior-period comparison, so it does not show whether the value rose or fell.
Unaudited net asset value per common share: $3.05
Measurement date: September 30, 2026
Filed under Item 8.01 (Other Events) on October 16, 2026, signed by Principal Financial Officer Nelson Joseph
On October 14, 2026, Copart's board approved a 10-year stock option for 20,000,000 shares for CEO A. Jayson Adair, granted outside the company's 2007 Equity Incentive Plan. The option cannot be exercised unless stockholders approve it at the 2026 Annual Meeting or a later special meeting, and it is forfeited if they do not. Shareholders may care because the award is large and is described as Adair's only substantive pay for the 10-year period, with a $1 annual salary and no expected bonus.
Option covers 20,000,000 shares in four tranches of 5,000,000 shares at $26.27, $35.03, $43.78 and $52.54 per share
Option has a 10-year term and first becomes exercisable on the 5th anniversary of the October 14, 2026 grant date, subject to continued service as CEO
Requires stockholder approval at the 2026 Annual Meeting or a special meeting after it; otherwise forfeited in full
Adair is expected to receive a $1 salary each year and no bonus or additional equity awards during the 10-year period
WidePoint Corporation's Chief Financial Officer, Robert George, tendered his resignation on October 9, 2026, citing personal and family reasons and stating no disagreement with the company. The resignation takes effect when the Form 10-Q for the quarter ended September 30, 2026 is filed, and he will assist in a non-officer role during the transition.
Robert George resigned as Chief Financial Officer; notice dated October 9, 2026
Resignation effective upon filing of the Form 10-Q for the quarter ended September 30, 2026
Resignation is for personal and family reasons, not a disagreement with the company
Mr. George will continue in a non-officer capacity to support an orderly transition
Atlantic American Corporation amended its revolving credit agreement with Truist Bank twice in October 2026, extending deadlines for delivering its audited 2025 financial statements and related covenant compliance certificates. The Fifth Amendment moves the audited statements deadline to October 23, 2026, waives related prior defaults, and sets a minimum AM Best rating of "A-" for subsidiary American Southern Insurance Company. The filing shows the company needed more time to deliver audited results to its lender, which is relevant to shareholders because it reflects a delay in the financial reporting timeline and a covenant-related waiver.
Fourth Amendment dated October 9, 2026 extended the audited 2025 statements deadline to October 15, 2026 and interim 2026 quarterly statements to November 30, 2026.
Fifth Amendment dated October 15, 2026 extended the audited 2025 statements deadline to October 23, 2026.
Fifth Amendment waived defaults under the Credit Agreement occurring before October 15, 2026.
Minimum AM Best financial strength rating for American Southern Insurance Company set at no lower than "A-".
Lion Copper Corp. said it received approval from Nasdaq to list its common shares on the Nasdaq Capital Market under the symbol LCU, with trading expected to begin October 19, 2026, subject to customary listing conditions. The shares will keep trading on the Canadian Securities Exchange, and OTCQB quotation is expected to end once Nasdaq trading starts. The filing does not include financial results or a financing.
Nasdaq trading under LCU expected to start at market open on Monday, October 19, 2026
Shares will continue to trade on the Canadian Securities Exchange under LCU
OTCQB quotation under LCGMF expected to cease when Nasdaq trading begins
Company says no action is required from shareholders
The Fund reported preliminary results of its transferable rights offering, which expired on October 15, 2026. Rights holders are expected to subscribe for about 3,582,068 Common Shares, for anticipated gross proceeds of about $70 million before offering expenses, at a subscription price of $19.28 per share. The figures are preliminary and remain subject to receipt of shareholder payments.
The offering began September 21, 2026 and expired at 5:00 p.m. Eastern Time on October 15, 2026.
Up to 10,545,755 Common Shares were available; about 3,582,068 are expected to be issued, including notices of guaranteed delivery.
The subscription price was $19.28 per Common Share, based on a formula tied to NYSE closing prices and net asset value.
Shares are expected to be issued on or about October 22, 2026, following receipt of all shareholder payments.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.